Second medical use
Generics succeed against Sanofi over cancer drug cabazitaxel
Several generic drug companies scored a win at the UPC against Sanofi's second medical use patent for cabazitaxel. In a decision issued today, the local division Munich revoked the patent, which forms
...
12 December 2025 by Konstanze Richter